LIGHTNEEDLE300 – 508A
Passive PBM Therapy
Lightneedle 300 offers 6x 655nm red laser / 50mw to instigate strong absorption and haemoglobin and anti-bacterial effects. It belongs to the family of laser attachments that attach to the Physiolaser Olympic and once it is connected to the Physiolaser Control Unit it can access all the pre-programmed treatments that the Physiolaser has to offer.
Passive PBM Therapy is primarily performed to provide support to the biological system by way of improving blood chemistry, blood oxygen transport, nitric oxide levels, immunological and hemopoietic indices and red blood cell count
PROVIDES
- 1 Passive Therapy
- 2 5-15 Minutes
- 3 Risk Free
- 4 Relaxing
- 5 Highly Effective
- 6 Painless
LightNeedle300 is the ideal therapy before and after professional sports activity and prolonged physical endurance e.g. marathon running and systemic rehabilitation therapy is highly recommended after all forms of surgery and orthopaedic injury to accelerate recovery time and as a support therapy for chronic illness.
Blood phototherapy was originally developed in Russia and introduced using He Ne laser intravenously in 1981 by Meshalkin and Sergievskiy.
Lightneedle300 passive PBM therapy completely avoids the risk associated with intravenous blood phototherapy
LightNeedle300 Non-Invasive PBM Therapy is recommended for improving blood oxygen and blood chemistry, which may be beneficial support as a support therapy for the following conditions:
- 1 Diabetes Mellitus
- 2 Lipid Metabolism Disorders
- 3 Chronic Liver and Kidney disorders
- 4 Respiratory
- 5 Cardiovascular Disease
- 6 Depression, Burn-out syndrome
- 7 CFS (Chronic Fatigue Syndrome)
- 8 Pain Syndromes/Arthritis
- 9 Polyneuropathy
- 10 Neurological Degeneration
- 11 Multiple Sclerosis
- 12 Alzheimers Disease
- 13 Parkinsons Disease
- 14 Brain Trauma
- 15 Psoriasis, Eczema, Burn Injury
- 16 Infected wounds and ulcers
- 17 Osteomyelitis
- 18 Post Stroke and Heart Attack
BLOODS RESEARCH
Effect of intravenous laser blood irradiation on endothelial dysfunction in patients with hypertensive disease
Burduli NM, Aleksandrova O. M. Klin Med (Mosk). 2009;87(6):22-5 PMID: 19670711 [PubMed-indexed for MEDLINE]
The aim of this work was to study effect of intravenous laser blood irradiation (IBL) on endothelial dysfunction in 120 patients (mean age 53.4+/-1.3yr) with grade I-II hypertensive disease (HD) allocated to 2 groups. Traditional drug therapy given to patients of the control group was supplemented by ILBI using a Mulat laser therapy device in the study group. Endothelial function was evaluated from the total plasma concentration of stable NOx metabolites, nitrates (NO3), nitrites (NO2), and Willebrand’s factor. HD patients were found to have elevated activity of Willebrands factor and show 3 types of response of the NO generating system:
(1) decreased NO synthesis, (2) lack of its changes, and (3) increased NO synthesis. NO production in HD patients negatively correlated with systolic(r=-0.59) and diastolic (R=-0.64) arterial pressure (AP) which suggests the relationship between decreased NO production and elevated AP.
Inclusion of ILBI in the therapy of Hypertensive Disease (HD) resulted in a significant decrease of Willebrand’s factor and normalisation of the NO level regardless of its initial value.
- Product Info
-
Lightneedle 300 offers 6x 655nm red laser / 50mw to instigate strong absorption and haemoglobin and anti-bacterial effects. It belongs to the family of laser attachments that attach to the Physiolaser Olympic and once it is connected to the Physiolaser Control Unit it can access all the pre-programmed treatments that the Physiolaser has to offer.
Passive PBM Therapy is primarily performed to provide support to the biological system by way of improving blood chemistry, blood oxygen transport, nitric oxide levels, immunological and hemopoietic indices and red blood cell count
PROVIDES
- 1 Passive Therapy
- 2 5-15 Minutes
- 3 Risk Free
- 4 Relaxing
- 5 Highly Effective
- 6 Painless
LightNeedle300 is the ideal therapy before and after professional sports activity and prolonged physical endurance e.g. marathon running and systemic rehabilitation therapy is highly recommended after all forms of surgery and orthopaedic injury to accelerate recovery time and as a support therapy for chronic illness.
Blood phototherapy was originally developed in Russia and introduced using He Ne laser intravenously in 1981 by Meshalkin and Sergievskiy.
Lightneedle300 passive PBM therapy completely avoids the risk associated with intravenous blood phototherapy - Recommended For
-
LightNeedle300 Non-Invasive PBM Therapy is recommended for improving blood oxygen and blood chemistry, which may be beneficial support as a support therapy for the following conditions:
- 1 Diabetes Mellitus
- 2 Lipid Metabolism Disorders
- 3 Chronic Liver and Kidney disorders
- 4 Respiratory
- 5 Cardiovascular Disease
- 6 Depression, Burn-out syndrome
- 7 CFS (Chronic Fatigue Syndrome)
- 8 Pain Syndromes/Arthritis
- 9 Polyneuropathy
- 10 Neurological Degeneration
- 11 Multiple Sclerosis
- 12 Alzheimers Disease
- 13 Parkinsons Disease
- 14 Brain Trauma
- 15 Psoriasis, Eczema, Burn Injury
- 16 Infected wounds and ulcers
- 17 Osteomyelitis
- 18 Post Stroke and Heart Attack
- Research
-
BLOODS RESEARCH
Effect of intravenous laser blood irradiation on endothelial dysfunction in patients with hypertensive disease
Burduli NM, Aleksandrova O. M. Klin Med (Mosk). 2009;87(6):22-5 PMID: 19670711 [PubMed-indexed for MEDLINE]
The aim of this work was to study effect of intravenous laser blood irradiation (IBL) on endothelial dysfunction in 120 patients (mean age 53.4+/-1.3yr) with grade I-II hypertensive disease (HD) allocated to 2 groups. Traditional drug therapy given to patients of the control group was supplemented by ILBI using a Mulat laser therapy device in the study group. Endothelial function was evaluated from the total plasma concentration of stable NOx metabolites, nitrates (NO3), nitrites (NO2), and Willebrand’s factor. HD patients were found to have elevated activity of Willebrands factor and show 3 types of response of the NO generating system:
(1) decreased NO synthesis, (2) lack of its changes, and (3) increased NO synthesis. NO production in HD patients negatively correlated with systolic(r=-0.59) and diastolic (R=-0.64) arterial pressure (AP) which suggests the relationship between decreased NO production and elevated AP.
Inclusion of ILBI in the therapy of Hypertensive Disease (HD) resulted in a significant decrease of Willebrand’s factor and normalisation of the NO level regardless of its initial value.